genedrive

Genedrive plc is a UK-based biotechnology company that focuses on developing and commercializing low-cost, rapid, and portable molecular diagnostic tests, primarily for infectious diseases. Founded in 2000 and headquartered in Manchester, the company rebranded from Epistem Holdings plc to Genedrive plc in 2016. The company is known for its flagship product, the world's first portable diagnostic test for Hepatitis C virus, which is designed for use in decentralized, low-resource settings. This technology enables timely and affordable diagnosis, particularly in developing regions like Asia Pacific and Africa. Genedrive also offers portable molecular diagnostic kits for point-of-need testing and pharmacogenetic testing solutions that provide insights into patient drug responses. The company invests in research and development to expand its assay portfolio and enhance diagnostic technologies, targeting healthcare providers and public health organizations in resource-limited settings. Genedrive plc is publicly listed on the London Stock Exchange’s AIM market under the ticker GDR.

• Employees 43
• Founded 2016
• Annual Revenue $633000
• Total Funding $2760840